The advantage of chimeric antigen receptor T cell therapy in pediatric acute lymphoblastic leukemia with E2A-HLF fusion gene positivity: a case series.

Wu, Shuiyan; Lu, Jun; Su, Dongni; Yang, Fan; Zhang, Yongping; Hu, Shaoyan

Wu, Shuiyan; Lu, Jun; Su, Dongni; Yang, Fan; Zhang, Yongping; Hu, Shaoyan.

Afiliación

Wu S; Department of Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, China.
Lu J; Department of Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, China.
Su D; Department of Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, China.
Yang F; Department of Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, China.
Zhang Y; Department of Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, China.
Hu S; Department of Hematology & Oncology, Children's Hospital of Soochow University, Suzhou, China.

Transl Pediatr ; 10(3): 686-691, 2021 Mar.

Article en En | MEDLINE | ID: mdl-33880339

Palabras clave

CAR-T cells therapy; E2A-HLF; acute lymphoblastic leukemia (ALL); case series; pediatric

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Transl Pediatr Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google